Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment☆
Author(s) -
Jorge A. Wernly,
Charles A. Dietl,
Cyril Etta Tabe,
Stuart B. Pett,
Cameron Crandall,
Karen Milligan,
Mark R. Crowley
Publication year - 2011
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2011.01.089
Subject(s) - medicine , extracorporeal membrane oxygenation , surgery , refractory (planetary science) , group b , percutaneous , anesthesia , cardiopulmonary bypass , membrane oxygenator , physics , astrobiology
The aim of the study was to evaluate the outcome of extracorporeal membrane oxygenation (ECMO) support in Hantavirus cardiopulmonary syndrome (HCPS) patients with a predicted mortality of 100%, and the complications associated with this treatment modality and different cannulation techniques.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom